Prosecution Insights
Last updated: November 13, 2026
Application No. 18/757,296

HIV Specific Binding Molecules and Uses Thereof

Non-Final OA
Filed
Jun 27, 2024
Priority
Feb 20, 2022 — provisional 63/312,077 +1 more
Examiner
CHEONG, CHEOM-GIL
Art Unit
1645
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Immunocore Limited
OA Round
1 (Non-Final)
65%
Grant Probability
Moderate
1-2
OA Rounds
99%
With Interview

Examiner Intelligence

Grants 65% of resolved cases
65%
Career Allowance Rate
127 granted / 196 resolved
+4.8% vs TC avg
Strong +53% interview lift
Without
With
+52.7%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
33 currently pending
Career history
227
Total Applications
across all art units

Prosecution Timeline

Jun 27, 2024
Application Filed
Jun 08, 2026
Examiner Interview (Telephonic)
Jun 22, 2026
Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12790394
COMPOSITIONS AND METHODS FOR TARGETING CD33-EXPRESSING CANCERS
2y 4m to grant Granted Nov 10, 2026
Patent 12790396
Antibodies Binding to Vista at Acidic pH
1y 11m to grant Granted Nov 10, 2026
Patent 12760115
ANTIBODIES AGAINST CLAUDIN 18.2 USEFUL IN CANCER DIAGNOSIS
2y 6m to grant Granted Oct 13, 2026
Patent 12746280
CHAGAS DISEASE VACCINE ANTIGENS WITH IMPROVED STABILITY AND DECREASED AGGREGATION
4y 5m to grant Granted Sep 29, 2026
Patent 12747289
MANUFACTURING METHODS FOR PRODUCING ANTI-IL12/IL23 ANTIBODY COMPOSITIONS
2y 8m to grant Granted Sep 29, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
65%
Grant Probability
99%
With Interview (+52.7%)
Low
PTA Risk
Based on 196 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month